» Articles » PMID: 27085772

Unraveling the Actions of AMP-activated Protein Kinase in Metabolic Diseases: Systemic to Molecular Insights

Overview
Journal Metabolism
Specialty Endocrinology
Date 2016 Apr 18
PMID 27085772
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

AMP-activated protein kinase (AMPK) plays a critical role both in sensing and regulating cellular energy state. In experimental animals, its activation has been shown to reduce the risk of obesity and diabetes-related co-morbidities such as insulin resistance, the metabolic syndrome and atherosclerotic cardiovascular disease. However, in humans, AMPK activation alone often does not completely resolve these conditions. Thus, an improved understanding of AMPK action and regulation in metabolic and other diseases is needed. Herein, we provide a brief description of the enzymatic regulation of AMPK and review its role in maintaining energy homeostasis. We then discuss tissue-specific actions of AMPK that become distorted during such conditions as obesity, type 2 diabetes and certain cancers. Finally, we explore recent findings regarding the interactions of AMPK with mammalian target of rapamycin complex 1 and the lysosome and discuss how changes in these relationships during overnutrition may lead to AMPK dysfunction. A more thorough understanding of AMPK's molecular interactions during diseases of overnutrition may provide key insights for the development of AMPK-based combinatorial treatments for metabolic disease.

Citing Articles

AMPK: The energy sensor at the crossroads of aging and cancer.

Penugurti V, Manne R, Bai L, Kant R, Lin H Semin Cancer Biol. 2024; 106-107:15-27.

PMID: 39197808 PMC: 11625618. DOI: 10.1016/j.semcancer.2024.08.002.


Cannabidiol and Beta-Caryophyllene Combination Attenuates Diabetic Neuropathy by Inhibiting NLRP3 Inflammasome/NFκB through the AMPK/sirT3/Nrf2 Axis.

Khan I, Kaur S, Rishi A, Boire B, Aare M, Singh M Biomedicines. 2024; 12(7.

PMID: 39062016 PMC: 11274582. DOI: 10.3390/biomedicines12071442.


Targeting Protein Kinases to Protect Beta-Cell Function and Survival in Diabetes.

Dalle S Int J Mol Sci. 2024; 25(12).

PMID: 38928130 PMC: 11203834. DOI: 10.3390/ijms25126425.


Sakurasosaponin inhibits lung cancer cell proliferation by inducing autophagy via AMPK activation.

Seo Y, Lim C, Lee J, Kim J, Kim Y, Lee P Oncol Lett. 2023; 26(6):501.

PMID: 37920436 PMC: 10618918. DOI: 10.3892/ol.2023.14088.


Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism.

Oliver H, Ruta D, Thompson D, Kamli-Salino S, Philip S, Wilson H J Transl Med. 2023; 21(1):715.

PMID: 37828508 PMC: 10568790. DOI: 10.1186/s12967-023-04598-2.


References
1.
Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z . AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 2013; 17(1):113-24. PMC: 3545102. DOI: 10.1016/j.cmet.2012.12.001. View

2.
Li F, Lam K, Tse H, Chen C, Wang Y, Vanhoutte P . Endothelium-selective activation of AMP-activated protein kinase prevents diabetes mellitus-induced impairment in vascular function and reendothelialization via induction of heme oxygenase-1 in mice. Circulation. 2012; 126(10):1267-77. DOI: 10.1161/CIRCULATIONAHA.112.108159. View

3.
Las G, Serada S, Wikstrom J, Twig G, Shirihai O . Fatty acids suppress autophagic turnover in β-cells. J Biol Chem. 2011; 286(49):42534-42544. PMC: 3234912. DOI: 10.1074/jbc.M111.242412. View

4.
Suzuki T, Bridges D, Nakada D, Skiniotis G, Morrison S, Lin J . Inhibition of AMPK catabolic action by GSK3. Mol Cell. 2013; 50(3):407-19. PMC: 3654099. DOI: 10.1016/j.molcel.2013.03.022. View

5.
Liu X, Niu Y, Yuan H, Huang J, Fu L . AMPK binds to Sestrins and mediates the effect of exercise to increase insulin-sensitivity through autophagy. Metabolism. 2015; 64(6):658-65. DOI: 10.1016/j.metabol.2015.01.015. View